Deepverge PLC Exercise of Options and Total Voting Rights (7248U)
April 07 2021 - 10:43AM
UK Regulatory
TIDMDVRG
RNS Number : 7248U
Deepverge PLC
07 April 2021
AIM share code: DVRG
7 April 2021
DeepVerge PLC
("DeepVerge" or "Company")
Exercise of Options
DeepVerge announces that it has received notification from UK
EMI employee share option holders to exercise 18,102 shares in the
issued share capital of DeepVerge ("the Option Shares"). The
consideration for the exercise of the Option Shares at nominal
value of 0.1p amounts, in aggregate, to a cash value of
GBP18.10.
Application will be made for the Option Shares to be admitted to
trading on AIM ("Admission"). Admission is expected to be on or
about 13 April 2021.
Total voting rights
The Company's total issued capital, after the issue of the
Option Shares, will be 173,195,661 ordinary shares. As the Company
does not hold any shares in Treasury, this figure may be used by
shareholders in the Company as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change to their interest in, the share capital of
the Company following Admission.
Contacts
+44 (0) 7340 055
DeepVerge plc Gerard Brandon, CEO 648
SPARK Advisory Partners
Limited Neil Baldwin/Andrew +44 (0) 113 370
(Nominated Adviser) Emmott 8974
Turner Pope Investments Andy Thacker/Zoe +44 (0) 20 3657
(TPI) Limited (Broker) Alexander 0050
About DeepVerge plc (www.deepverge.com)
DeepVerge is an environmental and life science group of
companies that develops and applies AI and IoT technology to
analytical instruments for the analysis and identification of
bacteria, virus and toxins. Utilising artificial intelligent data
analytics to scientifically prove the impact of skincare product
claims on skin microbiome for most of the top 20 global cosmetic
company clients and remotely detect and identify in real-time,
dangerous pathogens in wastewater treatment plants, drinking water,
rivers, lakes and reservoirs.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEBSGDSGSGDGBR
(END) Dow Jones Newswires
April 07, 2021 10:43 ET (14:43 GMT)
Integumen (LSE:SKIN)
Historical Stock Chart
From Apr 2024 to May 2024
Integumen (LSE:SKIN)
Historical Stock Chart
From May 2023 to May 2024